Gabor Mezei, M.D., Ph.D.
Dr. Gabor Mezei is a Senior Managing Scientist in Exponent’s Health Sciences Center for Epidemiology and Computational Biology. Dr. Mezei has over 25 years of experience in health research including epidemiological studies of both clinical outcomes and environmental and occupational health issues. His current work primarily focuses on health research related to electromagnetic fields (EMF) and asbestos exposures, and wearable electronics. He has considerable experience in conducting complex health assessment and exposure characterization studies related to power frequency and radiofrequency EMF. Previously, at the Electric Power Research Institute, he was responsible for leading a multidisciplinary scientific research program aimed at addressing potential human health effects associated with residential and occupational exposure to power frequency and radiofrequency EMF.
Dr. Mezei trained as a medical doctor (M.D.) at the Semmelweis University of Medicine in Budapest, Hungary, and as an epidemiologist (Ph.D.) at the School of Public Health of the University of California in Los Angeles (UCLA). He was the recipient of Fogarty and Fulbright Fellowships. He served as an affiliate associate professor at the Department of Environmental and Occupational Health Sciences of the University of Washington in Seattle, Washington, as a visiting scientist at the Hungarian National Research Institute for Radiobiology and Radiohygiene in Budapest, Hungary, and as a research associate at the Toronto Western Hospital, University of Toronto. Dr. Mezei lectured at Stanford University, the UCLA School of Public Health, and the Electrotechnical Committee of the Hungarian Academy of Sciences, and appeared as an EMF health expert in hearings at several state (US) and provincial (Canada) public utility commissions and a parliamentary committee in Ireland.
Dr. Mezei is an author or co-author of over 60 scientific publications and book chapters on topics related to epidemiology of environmental and occupational exposures and chronic diseases, adverse clinical outcomes, and environmental exposure assessment.